If ERα is also regulated by DSCAM‐AS1, they may form a positive feedback, which means ERα and DSCAM‐AS1 can maintain their high expression each other in luminal (ER+) breast cancer. This evidence concerns the gene DSCAM-AS1 and breast carcinoma.